Table 1.
Antihypertensive drug treatment at baseline and follow-up, CoLaus study
| Baseline | Follow-up | |
|---|---|---|
| Diuretics (%) |
392 (46.9) |
330 (42.8) |
| As main treatment (%) |
93 (12.1) |
108 (14.0) |
| Associated with other drugs (%) |
293 (38.0) |
240 (31.1) |
| Angiotensin receptor blockers (%) |
345 (44.7) |
399 (51.7) |
| Angiotensin converting enzyme inhibitors (%) |
222 (28.8) |
197 (25.5) |
| Beta-blockers (%) |
216 (28.0) |
255 (33.0) |
| Calcium channel blockers (%) |
146 (18.9) |
160 (20.7) |
| Other (%) |
2 (0.3) |
8 (1.0) |
| Number of antihypertensive classes (%) |
|
|
| 0 |
- |
46 (6.0) |
| 1 |
368 (47.7) |
293 (38.0) |
| 2 |
296 (38.3) |
270 (35.0) |
| 3+ | 108 (14.0) | 163 (21.0) |
Results are expressed as number of participants and (percentage). The total number of participants (772) was used as denominator to calculate percentages.